1. Home
  2. ZURA vs NOA Comparison

ZURA vs NOA Comparison

Compare ZURA & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$4.37

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

NOA

North American Construction Group Ltd. (no par)

HOLD

Current Price

$14.80

Market Cap

434.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZURA
NOA
Founded
2022
1953
Country
United States
Canada
Employees
40
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
434.5M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
ZURA
NOA
Price
$4.37
$14.80
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
627.8K
75.3K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
2.40%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.77
Revenue Next Year
N/A
$5.43
P/E Ratio
N/A
$18.05
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$12.07
52 Week High
$7.25
$18.24

Technical Indicators

Market Signals
Indicator
ZURA
NOA
Relative Strength Index (RSI) 38.08 51.71
Support Level $3.33 $14.36
Resistance Level $4.58 $16.02
Average True Range (ATR) 0.36 0.60
MACD -0.03 -0.02
Stochastic Oscillator 26.33 36.51

Price Performance

Historical Comparison
ZURA
NOA

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: